Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Reply to Polverino: Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?

Ladjemi MZ, Burgel PR, Pilette C.

Am J Respir Crit Care Med. 2019 May 1;199(9):1171-1172. doi: 10.1164/rccm.201812-2249LE. No abstract available.

2.

Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.

Aboubakar Nana F, Lecocq M, Ladjemi MZ, Detry B, Dupasquier S, Feron O, Massion PP, Sibille Y, Pilette C, Ocak S.

Mol Cancer Ther. 2019 Jan;18(1):17-27. doi: 10.1158/1535-7163.MCT-18-0328. Epub 2018 Oct 23.

3.

Increased IgA Expression in Lung Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease.

Ladjemi MZ, Martin C, Lecocq M, Detry B, Nana FA, Moulin C, Weynand B, Fregimilicka C, Bouzin C, Thurion P, Carlier F, Serré J, Gayan-Ramirez G, Delos M, Ocak S, Burgel PR, Pilette C.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):592-602. doi: 10.1164/rccm.201802-0352OC.

PMID:
30339768
4.

Reply to Upham: The Bronchial Epithelial Secretory IgA System in Asthma.

Ladjemi MZ, Gras D, Gohy S, Chanez P, Pilette C.

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1236-1238. doi: 10.1164/rccm.201806-1128LE. No abstract available.

PMID:
30059234
5.

Bronchial Epithelial IgA Secretion Is Impaired in Asthma. Role of IL-4/IL-13.

Ladjemi MZ, Gras D, Dupasquier S, Detry B, Lecocq M, Garulli C, Fregimilicka C, Bouzin C, Gohy S, Chanez P, Pilette C.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1396-1409. doi: 10.1164/rccm.201703-0561OC.

PMID:
29652177
6.

Lung lymphoid neogenesis in cystic fibrosis: a model of adaptive responses to bacteria?

Gohy ST, Ladjemi MZ, Pilette C.

Eur Respir J. 2017 Apr 26;49(4). pii: 1700380. doi: 10.1183/13993003.00380-2017. Print 2017 Apr. No abstract available.

7.

Interleukin-1α: a key player for epithelial-to-mesenchymal signalling in COPD?

Froidure A, Ladjemi MZ, Pilette C.

Eur Respir J. 2016 Aug;48(2):301-4. doi: 10.1183/13993003.01180-2016. No abstract available.

8.

Chronic inflammatory airway diseases: the central role of the epithelium revisited.

Gohy ST, Hupin C, Pilette C, Ladjemi MZ.

Clin Exp Allergy. 2016 Apr;46(4):529-42. doi: 10.1111/cea.12712. Review.

PMID:
27021118
9.

Mite allergen-specific IgE is detectable in bronchial secretions of patients with nonatopic asthma and correlates with mucosal expression of periostin.

Mouthuy J, Viart S, Ladjemi MZ, Detry B, Henket M, Bachert C, Louis R, Pilette C.

J Allergy Clin Immunol. 2015 Dec;136(6):1685-1688.e2. doi: 10.1016/j.jaci.2015.07.018. Epub 2015 Aug 29. No abstract available.

10.

Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition.

Gohy ST, Hupin C, Fregimilicka C, Detry BR, Bouzin C, Gaide Chevronay H, Lecocq M, Weynand B, Ladjemi MZ, Pierreux CE, Birembaut P, Polette M, Pilette C.

Eur Respir J. 2015 May;45(5):1258-72. doi: 10.1183/09031936.00135814. Epub 2015 Mar 5.

11.

Increased IgA production by B-cells in COPD via lung epithelial interleukin-6 and TACI pathways.

Ladjemi MZ, Lecocq M, Weynand B, Bowen H, Gould HJ, Van Snick J, Detry B, Pilette C.

Eur Respir J. 2015 Apr;45(4):980-93. doi: 10.1183/09031936.00063914. Epub 2014 Dec 23.

12.

Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements.

Ladjemi MZ.

Front Oncol. 2012 Nov 6;2:158. doi: 10.3389/fonc.2012.00158. eCollection 2012.

13.

Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.

Colombo PE, Boustta M, Poujol S, Jarlier M, Bressolle F, Teulon I, Ladjemi MZ, Pinguet F, Rouanet P, Vert M.

Gynecol Oncol. 2011 Sep;122(3):632-40. doi: 10.1016/j.ygyno.2011.05.032. Epub 2011 Jun 12.

PMID:
21665252
14.

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice.

Ladjemi MZ, Chardes T, Corgnac S, Garambois V, Morisseau S, Robert B, Bascoul-Mollevi C, Ait Arsa I, Jacot W, Pouget JP, Pelegrin A, Navarro-Teulon I.

Breast Cancer Res. 2011 Feb 4;13(1):R17. doi: 10.1186/bcr2826.

15.

Anti-HER2 vaccines: new prospects for breast cancer therapy.

Ladjemi MZ, Jacot W, Chardès T, Pèlegrin A, Navarro-Teulon I.

Cancer Immunol Immunother. 2010 Sep;59(9):1295-312. doi: 10.1007/s00262-010-0869-2. Epub 2010 Jun 8. Review.

16.

A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy.

Alvarez-Rueda N, Ladjemi MZ, Béhar G, Corgnac S, Pugnière M, Roquet F, Bascoul-Mollevi C, Baty D, Pèlegrin A, Navarro-Teulon I.

Vaccine. 2009 Jul 30;27(35):4826-33. doi: 10.1016/j.vaccine.2009.05.067. Epub 2009 Jun 11.

PMID:
19523913
17.

[Anti-HER2 vaccines: The HER2 immunotargeting future?].

Ladjemi MZ, Jacot W, Pèlegrin A, Navarro-Teulon I.

Pathol Biol (Paris). 2011 Jun;59(3):173-82. doi: 10.1016/j.patbio.2009.04.002. Epub 2009 May 28. Review. French.

18.

In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.

Larbouret C, Robert B, Navarro-Teulon I, Thèzenas S, Ladjemi MZ, Morisseau S, Campigna E, Bibeau F, Mach JP, Pèlegrin A, Azria D.

Clin Cancer Res. 2007 Jun 1;13(11):3356-62.

Supplemental Content

Loading ...
Support Center